Development of [64Cu]Cu-NODAGA-RGD-BBN as a Novel Radiotracer for Dual Integrin and GRPR-targeted Tumor PET Imaging

Author:

Amraee Naeimeh1,Alirezaour Behrouz2,Hosntalab Mohammad1,Hadadi Asghar1,Yousefnia Hassan1

Affiliation:

1. Faculty of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran

2. Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran

Abstract

Background: In this study, [64Cu]Cu-NODAGA-RGD-BBN was prepared and its preclinical assessments were evaluated for PET imaging of GRPR overexpressing tumors. background: Among the 64Cu peptide-based radiopharmaceuticals, ‎targeting of GRPRs, somatostatin receptors (SSTRs), and ‎integrins αvβ3, have received the most attention ‎ Methods: NODAGA-RGD-BBN heterodimer peptide was successfully labeled with cyclotronproduced copper-64 at optimized conditions. The radiochemical purity of the radiotracer was checked by HPLC and RTLC methods. The stability of the radiolabeled compound was assessed in PBS (4°C) and in human blood serum (37°C). Binding affinity and internalization of [64Cu]Cu-NODAGA-RGD-BBN were studied on PC3, LNCaP, and CHO cell lines. The biodistribution of the radiotracer was evaluated in normal and tumor-bearing mice. Results: [64Cu]Cu-NODAGA-RGD-BBN was prepared with radiochemical purity >99 ± 0.7% (HPLC/ITLC) and specific activity of 18.5 ± 2.2 TBq/mmol. The radiotracer showed high stability in PBS (95 ± 1.05%) and in human blood serum (96 ± 1.24%) and, high affinity to the GRP expressing tumor cells. [64Cu]Cu-NODAGA-RGD-BBN showed hydrophilic (log p = -1.14) and agonistic nature. The biodistribution and imaging studies demonstrated high uptake at the tumor site at all intervals post-injection and 3-4 h post-injection can be considered an appropriate time of imaging. method: NODAGA-RGD-BBN heterodimer peptide was successfully labelled with cyclotron-produced ‎copper-64 at optimized conditions. The radiochemical purity of the radiotracer was checked by ‎HPLC and RTLC methods. The stability of the radiolabeled compound was assessed in PBS (4 °C) ‎and in human blood serum (37 °C). Binding affinity and internalization of [64Cu]Cu-NODAGA-‎RGD-BBN were studied on PC3, LNCaP and CHO cell lines. The biodistribution of the radiotracer ‎was evaluated in normal and tumor-bearing mice. ‎ Conclusion: The results indicated that [64Cu]Cu-NODAGA-RGD-BBN radiolabeled heterodimer peptide can be considered as a high-potential agent for PET imaging of GRPRoverexpressing tumors.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3